Bourse
Stock filings

TAK insider trades & Congress trades

Takeda Pharmaceutical Co Ltd: public insider filings and Congress disclosures, in one place.

22insider buys + sells
0Congress trades
0 / 22insider buys / sells, 90 days
–latest buying cluster

Bourse has recorded 22 open-market insider transactions in Takeda Pharmaceutical Co Ltd (TAK) (0 purchases with code P and 22 sales with code S), the most recent on November 4, 2026.

In the last 90 days: 0 purchases by 0 insiders ($0) and 22 sales by 13 ($15.2M).

Insider transactions

SEC Form 4, open-market purchases (P) and sales (S) only. Awards, option exercises and tax withholding are excluded. “After” shows the stock’s return over the month following the trade, where available.

DateInsiderRoleTypeSharesPriceValueAfter 1M
Nov 4, 2026Platford Giles RichardPresident, IBUSell55,617$20.90$1.16M–
Nov 2, 2026Bitetti Teresa MariePresident, OBUSell46,609$20.89$974K–
Sep 14, 2026Duprey Lauren RusckowskiChief Transformation OfficerSell34,535$18.54$640K+0.0%
Sep 2, 2026Plump Andrew StewartPresident, R&DSell116,191$18.49$2.15M−0.0%
Aug 19, 2026Plump Andrew StewartPresident, R&DSell19,651$18.49$363K+0.0%
Aug 18, 2026Greenway Nicola Deidre PetalChief Human Resources OfficerSell12,980$18.11$235K+0.0%
Aug 11, 2026Shannon Elaine MaryPres., Global Supply & QualitySell20,363$17.55$357K+0.0%
Aug 10, 2026Furney Natalie Anne MarieGlobal General CounselSell30,868$17.10$528K+0.0%
Aug 10, 2026Platford Giles RichardPresident, IBUSell31,083$17.10$532K+0.0%
Aug 10, 2026Kim Julie So-YoungPresident and CEOSell89,090$17.10$1.52M+0.0%
Aug 10, 2026Greenway Nicola Deidre PetalChief Human Resources OfficerSell6,774$17.10$116K+0.0%
Aug 10, 2026Ricci GabrieleChief Data & Tech. OfficerSell25,088$17.10$429K+0.0%
Aug 10, 2026Shannon Elaine MaryPres., Global Supply & QualitySell3,978$17.10$68K+0.0%
Aug 10, 2026Bitetti Teresa MariePresident, OBUSell50,012$17.10$855K+0.0%
Aug 10, 2026Pignagnoli Agosti MarcelloHead, Strat. & Port. DevSell22,957$17.10$393K+0.0%
Aug 10, 2026Plump Andrew StewartPresident, R&DSell165,393$17.10$2.83M+0.0%
Aug 10, 2026Duprey Lauren RusckowskiChief Transformation OfficerSell47,586$17.10$814K+0.0%
Aug 10, 2026Ibrahim Ramy Riad AhmedPresident, PDT BUSell7,277$17.10$124K+0.0%
Aug 10, 2026Pacheco Rhonda JanicePresident, U.S. Business UnitSell16,901$17.10$289K+0.0%
Aug 10, 2026Farajallah Awny Samaan BotrosChief Medical OfficerSell14,006$17.10$240K+0.0%
Aug 10, 2026Greenway Nicola Deidre PetalChief Human Resources OfficerSell975$17.50$17K+0.0%
Aug 10, 2026Greenway Nicola Deidre PetalChief Human Resources OfficerSell33,628$17.51$589K+0.0%

Data as of November 8, 2026. Public filings only. A purchase or sale by a politician or an insider does not by itself imply any wrongdoing.

New to these filings? Read how to read a Form 4, how Congress trades are disclosed and what insider cluster buying means. Sources and limits are on the Methodology page.

See these filings as they land

Bourse collects Congress trades, SEC Form 4 insider filings and 13F fund holdings in one live feed, and flags insider buying clusters automatically. Free to start.

Bourse provides financial data and editorial information, parts of which are generated by AI. This page is for general education only. It is not personalised investment advice or a recommendation to buy or sell any financial instrument. Make your own decisions.